ALSO NOTED: Actelion touts study results; Genizon gains $10 million; Investor buys into Enzo; and much more...

> Switzerland's Actelion announced that a proof of concept study for its insomnia drug met its primary endpoint. Release

> Genizon BioSciences has gained $10 million in financing. Genizon will use the funds to conduct genome-wide association studies in the Quebec Founder Population and to enhance and commercialize discoveries. Pfizer and BTF of Haarlem, The Netherlands, both participated in the venture round. Release

> An unnamed investor has acquired 1 million shares of Enzo Biochem for $15 apiece. Release

And Finally… Texas became the first state in the U.S. to mandate that all sixth grade girls be given a vaccine against cervical cancer. Report

Suggested Articles

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.